Compare Meta Platforms Inc (META) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Meta Platforms Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Meta Platforms Inc trades at $730.6 (market cap $1.88T), while Vir Biotechnology Inc. Common Stock trades at $10.43 (market cap $1.76B). The key difference: Meta Platforms Inc is far larger — about 1068.2× Vir Biotechnology Inc. Common Stock's market cap, and Meta Platforms Inc pays a 0.28% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Meta Platforms Inc for 128 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| META | VIR | |
|---|---|---|
Market Cap | $1.88T | $1.76B |
Volume | 16,151,285 | 2,764,948 |
Sector | Media | Health |
52-Week High | $777.59 | $11.78 |
52-Week Low | $525.72 | $5.12 |
Typical Hold Time | 128 Days | 0 Days |
Enterprise Value | $1.90T | $1.32B |
Dividend Yield | 0.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
META stock trades at $762.50, up 2.63% ($19.54) today, reflecting strong momentum. The technical outlook is bullish, with the current price near resistance at $765. Fundamentally, revenue grew to $200.97B in 2025, with a net income margin of 29.84%, though earnings missed in Q2 2026. The recent launch of the Muse Spark AI model and a $21B deal with CoreWeave highlight strategic growth initiatives, while a youth addiction lawsuit in Massachusetts presents a regulatory headwind.
The investment outlook is positive, supported by robust analyst sentiment (81.16% buy ratings) and a consensus price target of $802.80, implying upside. Key opportunities include AI monetization and revenue diversification, but risks involve heightened regulatory scrutiny and significant capital expenditure pressures. Earnings performance in upcoming quarters will be critical for sustaining the bullish thesis.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
